Drawing for NETSURF DIRECT

USPTO serial 79262577

NETSURF DIRECT

Reviewed by CopyMark Law Group

Reg. 6071806Status 700Renewal
Filing date
Status date
Registration date
Jun 9, 2020
Examiner
SIMCOX, KYLE DUNCAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with NETSURF DIRECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $425

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander Lazouski

Alexander Lazouski Lazouski IP LLCSuite 1, 14726 Bowfin Ter.Lakewood Ranch, FL 48304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Acetates for pharmaceutical purposes; adjuvants for medical purposes; air purifying preparations; air deodorizing preparations and air deodorising preparations; albumin dietary supplements; albuminous foodstuffs for medical purposes, namely, albumin dietary supplements; albuminous preparations for medical purposes; alginates for pharmaceutical purposes; almond milk for pharmaceutical purposes; aloe vera preparations for pharmaceutical purposes; amino acids for medical purposes; anti-uric preparations; antibacterial soap; antibacterial handwashes; antioxidant pills being food supplements; antiparasitic preparations; appetite suppressants for medical purposes; appetite suppressant pills; asthmatic tea; astringents for medical purposes; balms for medical purposes; balsamic preparations for medical purposes; croton, condurango, angostura barks for pharmaceutical purposes; bath preparations for medical purposes; bath salts for medical purposes; bicarbonate of soda for pharmaceutical purposes; biological preparations for medical purposes, namely, nutraceuticals for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; camphor oil for medical purposes; camphor for medical purposes; candy, medicated; candy for medical purposes; capsules for medicines, sold empty; casein dietary supplements; castor oil for medical purposes; chemical preparations for pharmaceutical purposes, namely, for treating pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; chemical preparations for medical purposes, namely, for treating pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; chewing gum for medical purposes; collagen for medical purposes; Collyrium; cooling sprays for medical purposes; decoctions for pharmaceutical purposes, namely, for treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; dental abrasives; dental amalgams; mangrove bark for pharmaceutical purposes; deodorants for clothing and textiles; dietary fibre and dietary fiber to aid digestion; dietary supplements with a cosmetic effect; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods, beverages, infusions adapted for medical use; digestives for pharmaceutical purposes; disinfectant soap; disinfectants for hygiene purposes; pharmaceutical preparations, namely, elixirs for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; enzyme preparations for medical purposes; enzyme dietary supplements; enzymes for medical purposes; ferments for pharmaceutical purposes; first-aid boxes, filled; food for babies; glucose dietary supplements; gum being chewing gum for medical purposes; herbal teas for medicinal purposes; herbal extracts for medical purposes; infant formula; lecithin for medical purposes; lecithin dietary supplements; pediculicides being lice treatment preparations; lime-based pharmaceutical preparations for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; linseed for pharmaceutical purposes; flaxseed for pharmaceutical purposes; linseed meal for pharmaceutical purposes; flaxseed meal for pharmaceutical purposes; linseed dietary supplements; flaxseed dietary supplements; liquorice for pharmaceutical purposes; medicated eye-washes; diagnostic preparations for veterinary purposes; medicated dentifrices; medicated after-shave lotions; medicated shampoos; medicated toiletry preparations; medicated hair lotions; medicated dry shampoos; medicated soap; medicated massage candles for therapeutic purposes; medicinal tea; medicinal oils; medicinal herbs; medicinal drinks; medicinal hair growth preparations; medicines for alleviating constipation; medicines for dental purposes; medicines for human purposes, namely, for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; milk sugar for pharmaceutical purposes; lactose for pharmaceutical purposes; mineral food supplements; mint for pharmaceutical purposes; mouthwashes for medical purposes; myrobalan bark for pharmaceutical purposes; nutraceutical preparations for therapeutic or medical purposes, namely, for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; nutritional supplements; pharmaceuticals for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; phytotherapy preparations for medical purposes; plant extracts for pharmaceutical purposes; protein dietary supplements; purgatives; evacuants; sarsaparilla for medical purposes; smoking herbs for medical purposes; sugar for medical purposes; syrups for pharmaceutical purposes, namely, for the treatment of pain, inflammation, seizure and other neurological disorders, nausea, cancer and cancer related symptoms, anxiety and depresssion; tissues impregnated with pharmaceutical lotions; tobacco-free cigarettes for medical purposes, namely, for smoking cessation purposes; vitamin preparations; vitamin supplement patchesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 25, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 2, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 2, 2020FIMPFINAL DISPOSITION PROCESSED—
Sep 9, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 9, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 24, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 19, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 28, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 28, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 28, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2019RFNTREFUSAL PROCESSED BY IB—
Aug 20, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 20, 2019RFRRREFUSAL PROCESSED BY MPU—
Jul 25, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 24, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 19, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 15, 2019DOCKASSIGNED TO EXAMINER—
Jul 15, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance